Czechia· CZ-0296738

SULCEF

A cefoperazon und beta-lactamase-inhibitor product containing cefoperazone sodium + sulbactam sodium, registered in Czechia. The same ATC class is registered in 2 of our 19 countries.

ATC J01DD62

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedSULCEFATCJ01DD62REGISTER NO.CZ-0296738PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

Cefoperazon und beta-lactamase-inhibitor is registered in 2 of 19 countries.

Countries holding a registration under ATC J01DD62 (cefoperazon und beta-lactamase-inhibitor), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 2 of them publish a price we can compare per daily dose

Cefoperazon und beta-lactamase-inhibitor · ATC J01DD62

2 / 19 countries

  • Czechiaprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
CEFOPERAZONE SODIUM + SULBACTAM SODIUM
Manufacturer
—
Country
Czechia (CZ)
ATC code
J01DD62
ATC class
Cefoperazon und Beta-Lactamase-Inhibitor
Defined daily dose
4 g, P
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Cefoperazon und beta-lactamase-inhibitor in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefoperazon und beta-lactamase-inhibitor products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Bulgaria · Сулцеф, Цефопефаст-С
  • Cyprus · Sulbazon, Sulcef
  • Romania · Sulcef
  • Slovakia · Sulcef

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/392952bf-09d2-46c8-8cf4-bb30c65fd2f3
GET /v1/drugs/392952bf-09d2-46c8-8cf4-bb30c65fd2f3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INJ/INF PLV SOL",
  "source": "sukl",
  "strength": "2G",
  "pack_size": "10X(1G+1G)",
  "substance": "CEFOPERAZONE SODIUM + SULBACTAM SODIUM",
  "cz_kod_sukl": "0296738",
  "product_type": "CH",
  "substance_codes": "4636,9951",
  "registration_state": "F",
  "registration_number": null
}

See everything about cefoperazon und beta-lactamase-inhibitor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.